revenu consist januari pre-announc
on-going ep nickel better consensu expect revenu
guidanc larg unchang manag increas ep guidanc
breast health diagnost perform well
improv perform expect surgic cynosur reiter organ
revenu acceler thesi would ad exist posit due model
tax adjust ep declin yield target
growth street origin estim organ constant currenc
growth favor origin target fewer day trim
essenti apples-to-appl growth would breast health vs
street diagnost vs street favor origin
expect stronger blood screen revenu drove major diagnost upsid
vs although legaci busi still appear strong much-watch
cynosur busi grew sequenti line street forecast
gyn surgic disappoint quarter revenu miss
street target manag address sluggish result note leadership
chang like take sever quarter resum growth adjust gross margin
declin bpt larg due mix ou cyno higher op-ex
cynosur acquisit somewhat off-set on-going expens control measur
lower corpor rate led ep street estim
guidance/model updat larg left revenu guidanc unchang
slight reduct report unchang
increas on-going ep guidanc larg due
lower corpor tax rate like sever coverag compani let
portion benefit drop bottom line invest balanc across
variou project market support cynosur surgic busi
trim ep forecast better account tax chang
thought diagnost breast health perform well near-
term catalyst viral load brevera/affirm respect combin
expect greater growth surgical/cynosur increas confid
multi-year organ growth acceler thesi accordingli reiter ow rate
share would take advantag recent market volatil
new product adopt fda regul competit acquisit integr
inc focus provid health care product women
price close februari
ep
debt total capit
ep exclud one-tim item includ sbc
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
thousand
provis incom tax
product sale
good sold product sale
page
thousand
compani report piper jaffray co current disclosur inform compani locat
